Investor Presentation

We have a clear purpose to pioneer access for patients to become the world's leading and most valued Generics and Biosimilars company Purpose Pioneering access for patients Vision Becoming the world's leading and most valued Generics and Biosimilars company Impact ~500 million¹ >USD 180 billion² patients served per annum estimated annual social impact of Sandoz medicines 1. Based on internal analysis, 2. Based on 2022 WifOR Institute analysis. 4 Management Presentation SANDOZ

View entire presentation